N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142947 |
| CAS No | NA |
| Mol.F. | C7H17N3O2 |
| Mol.Wt. | 175.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142948 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142949 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142950 |
| CAS No | NA |
| Mol.F. | C19H26ClN5O6S |
| Mol.Wt. | 488 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142951 |
| CAS No | NA |
| Mol.F. | C16H20ClN5O2 |
| Mol.Wt. | 349.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142952 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O2 |
| Mol.Wt. | 336.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142953 |
| CAS No | NA |
| Mol.F. | C8H10N4O5S2 |
| Mol.Wt. | 306.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142954 |
| CAS No | NA |
| Mol.F. | C7H5Cl2N5O6S2 |
| Mol.Wt. | 390.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142955 |
| CAS No | NA |
| Mol.F. | C7H6Cl2N4O5S2 |
| Mol.Wt. | 361.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142956 |
| CAS No | NA |
| Mol.F. | C15H15Cl2N7O9S4 |
| Mol.Wt. | 636.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142957 |
| CAS No | NA |
| Mol.F. | C7H5ClN4O5S2 |
| Mol.Wt. | 324.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142958 |
| CAS No | NA |
| Mol.F. | C6H4ClN5O5S2 |
| Mol.Wt. | 325.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142959 |
| CAS No | NA |
| Mol.F. | C7H6ClN3O3S |
| Mol.Wt. | 247.65 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142960 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142961 |
| CAS No | NA |
| Mol.F. | C14H20N2O6 |
| Mol.Wt. | 312.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142962 |
| CAS No | NA |
| Mol.F. | C27H37N3O7 |
| Mol.Wt. | 515.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |